Toll-like receptor 5 polymorphism at position c. 1846T > C is associated with the development of hepatocellular carcinoma in caucasians with chronic hepatitis B infection

被引：0
|
作者：
Koukoulioti, E. [1 ]
Fischer, J. [1 ]
Schott, E. [2 ]
Fueloep, B. [1 ]
Heyne, R. [3 ]
Berg, T. [1 ]
van Boemmel, F. [1 ]
机构：
[1] Univ Leipzig Hosp & Clin, Hepatol Sect, Leipzig, Germany
[2] Campus Virchow Klinikum, Univ Hosp Charite, Dept Gastroenterol & Hepatol, Berlin, Germany
[3] Liver & Study Ctr Checkpoint, Berlin, Germany
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30986-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-319
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [21] Significance of Prior Hepatitis B Virus Infection in the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Fumio Imazeki
    Osamu Yokosuka
    Kenichi Fukai
    Akira Hiraide
    Hiromitsu Saisho
    Digestive Diseases and Sciences, 2003, 48 : 1786 - 1792
  • [22] Occult Hepatitis B Virus Infection and Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C Reply
    Lok, Anna S.
    Everhart, James E.
    HEPATOLOGY, 2011, 54 (01) : 374 - 374
  • [23] Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C
    Imazeki, F
    Yokosuka, O
    Fukai, K
    Hiraide, A
    Saisho, H
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (09) : 1786 - 1792
  • [24] The toll-like receptor 2 (TLR2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
    Nischalke, Hans-Dieter
    Coenen, Martin
    Berger, Cordula
    Aldenhoff, Katharina
    Mueller, Tobias
    Berg, Thomas
    Kraemer, Benjamin
    Koerner, Christian
    Odenthal, Margarete
    Schulze, Falko
    Gruenhage, Frank
    Nattermann, Jacob
    Sauerbruch, Tilman
    Spengler, Ulrich
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1470 - 1475
  • [25] Altered Expression of SHIP, a Toll-like Receptor Pathway Inhibitor, Is Associated With the Severity of Liver Fibrosis in Chronic Hepatitis C Virus Infection
    Katsounas, Antonios
    Trippler, Martin
    Kottilil, Shyam
    Lempicki, Richard A.
    Gerken, Guido
    Schlaak, Joerg F.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (08): : 1181 - 1185
  • [26] Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection
    Tsai, I-Ting
    Wang, Chao-Ping
    Yu, Teng-Hung
    Lu, Yung-Chuan
    Lin, Chih-Wen
    Lu, Li-Fen
    Wu, Cheng-Ching
    Chung, Fu-Mei
    Lee, Yau-Jiunn
    Hung, Wei-Chin
    Hsu, Chia-Chang
    CYTOKINE, 2017, 90 : 54 - 59
  • [27] Association of toll-like receptor gene 3 C6300T polymorphisms with inflammatory activity and liver cirrhosis in chronic hepatitis C virus infection
    Li, Q.
    Kato, N.
    Dharel, N.
    Moriyama, M.
    Shao, R.
    Muroyama, R.
    Chang, J.
    Kawabe, T.
    Omata, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S128 - S128
  • [28] The MICA but not the DEPDC5 polymorphism is associated with chronic hepatitis C-related hepatocellular carcinoma
    Hai, Hoang
    Tamori, Akihiro
    Yoshida, Kanako
    Hagihara, Atsushi
    Kawamura, Etsushi
    Fujii, Hideki
    Uchida, Sawako K.
    Iwai, Shuji
    Morikawa, Hiroyasu
    Enomoto, Masaru
    Murakami, Yoshiki
    Le, Thuy T.
    Kawada, Norifumi
    HEPATOLOGY, 2013, 58 : 918A - 918A
  • [29] The association between DEPDC5 polymorphism and the development of hepatocellular carcinoma in patients with chronic hepatitis C
    Nakamoto, Shingo
    Kanda, Tatsuo
    Wu, Shuang
    Jiang, Xia
    Miyamura, Tatsuo
    Arai, Makoto
    Fujiwara, Keiichi
    Saito, Kengo
    Imazeki, Fumio
    Shirasawa, Hiroshi
    Yokosuka, Osamu
    HEPATOLOGY, 2012, 56 : 668A - 669A
  • [30] Reduced expression and functional impairment of toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
    Yakushijin, T
    Kanto, T
    Inoue, M
    Miyazaki, M
    Itose, I
    Miyatake, H
    Sakakibara, M
    Kuzushita, N
    Hiramatsu, N
    Takehara, T
    Kasahara, A
    Hayashi, N
    HEPATOLOGY, 2005, 42 (04) : 247A - 247A
12345